Delivery Order SPE2DB20D1100-SPE2DB25FD5H1
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract (SPE2DX15D1022|SPE2DX24FVFVT) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product OPZELURA 1.5% Cream 60GM. The contract, with a ceiling value of $12,016.98, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and holds an indefinite delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,028.01 firm fixed price contract is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a performance period through February 19, 2025. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive vehicle for...
- This is a $3,612.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream in 60g quantities. The contract has an ultimate completion date of September 11, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a $1,793.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM and has a completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting various defense and civilian agencies. This delivery order is issued under a larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of OPZELURA 1.5% Cream in 60 gram quantities, with a completion date of February 21, 2024 and a potential value of $1,250.23. This delivery order is not associated with any set-aside designations. AmerisourceBergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024, and a ceiling value of $7,162.27. The award is not associated with a set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,250.23 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564028078 OPZELURA 1.5% CREAM 60GM. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to support military treatment programs and facilities...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,911.04, is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor for this award and the company is registered in the System for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,187.85, is for the supply of OPZELURA 1.5% cream in 60 gram units. The contract has a firm fixed price and a completion date of April 29, 2024. Amerisourcebergen Drug Corp is a subsidiary of the Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The company has significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,692.26, is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a period of performance through April 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5H1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,909.76 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM), a topical pharmaceutical product. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's substantial IDC vehicle enables the supply of comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. This specific delivery order for OPZELURA topical cream reflects the company's ongoing role in fulfilling targeted pharmaceutical needs for the Defense Health Agency and other federal healthcare customers through the DLA's Troop Support Medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/18/25 |